evans blue has been researched along with Ovarian Hyperstimulation Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardill, J; Caldwell, C; McClure, N; McElhinney, B | 1 |
| Endo, T; Kitajima, Y; Kudo, R; Manase, K; Nishikawa, A; Shibuya, M | 1 |
| Matsuura, K; Okamura, H; Tanaka, N; Ujioka, T | 1 |
3 other study(ies) available for evans blue and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Preventing ovarian hyperstimulation syndrome by inhibiting the effects of vascular endothelial growth factor.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Endothelial Growth Factors; Evans Blue; Female; Follicle Stimulating Hormone; Intercellular Signaling Peptides and Proteins; Lymphokines; Ovarian Hyperstimulation Syndrome; Probability; Protein-Tyrosine Kinases; Random Allocation; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Statistics, Nonparametric; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats.
Topics: Animals; Blotting, Northern; Blotting, Western; Capillary Permeability; Coloring Agents; Evans Blue; Female; Gonadotropin-Releasing Hormone; Hormones; Leuprolide; Organ Size; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Vascular Endothelial Growth Factor A | 2004 |
Involvement of ovarian kinin-kallikrein system in the pathophysiology of ovarian hyperstimulation syndrome: studies in a rat model.
Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Capillary Permeability; Chorionic Gonadotropin; Disease Models, Animal; Estradiol; Evans Blue; Female; Hormone Antagonists; Kallikreins; Kinins; Mifepristone; Ovarian Hyperstimulation Syndrome; Ovary; Peritoneum; Progesterone; Protease Inhibitors; Rats; Rats, Wistar | 1998 |